Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
European Review for Medical and Pharmacological Sciences|February 20, 2024
The endogenous oxytocin after manipulative osteopathic treatment in full-term pregnant womenA Ragusa, A Svelato, M Fogolari, et al.
British Journal of Cancer|August 22, 2002
Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: a multicenter phase II studyB Neri, G Cini, L Doni, et al.
European Journal of Neurology|December 17, 2016
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosisR Lanzillo, C Di Somma, M Quarantelli, et al.
Clinical Endocrinology|January 22, 2014
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumoursV Ramundo, M Del Prete, V Marotta, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 26, 2013
Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patientsI Meattini, L Livi, D Franceschini, et al.
Journal of Chemotherapy (Florence, Italy)|July 12, 2011
Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclinesL Livi, I Meattini, V Scotti, et al.
Annals of Neurology|December 23, 2011
Rare variants in the CYP27B1 gene are associated with multiple sclerosisSreeram V Ramagopalan, David A Dyment, M Zameel Cader, et al.
Neurology|June 30, 2012
Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 geneDavid A Dyment, M Zameel Cader, Michael J Chao, et al.
Genome Medicine|November 2, 2016
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's diseaseMinghui Wang, Panos Roussos, Andrew McKenzie, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 17, 2022
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into playR Infantino, S Boccella, D Scuteri, et al.
Pageof 17